Cresco Labs (CRLBF) to Release Quarterly Earnings on Friday

Cresco Labs (OTCMKTS:CRLBFGet Free Report) is expected to be issuing its quarterly earnings data before the market opens on Friday, March 21st. Analysts expect the company to announce earnings of ($0.02) per share for the quarter.

Cresco Labs (OTCMKTS:CRLBFGet Free Report) last issued its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). The company had revenue of $176.00 million during the quarter, compared to analysts’ expectations of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. On average, analysts expect Cresco Labs to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cresco Labs Stock Down 4.0 %

Shares of OTCMKTS CRLBF opened at $0.71 on Wednesday. The stock has a market cap of $344.14 million, a PE ratio of -3.53 and a beta of 1.79. The business has a fifty day moving average of $0.88 and a two-hundred day moving average of $1.19. Cresco Labs has a 52-week low of $0.70 and a 52-week high of $2.60. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Cormark raised Cresco Labs from a “hold” rating to a “moderate buy” rating in a report on Monday. Atb Cap Markets cut Cresco Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Cresco Labs currently has a consensus rating of “Buy” and an average price target of $3.00.

Get Our Latest Stock Report on CRLBF

Cresco Labs Company Profile

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Featured Stories

Earnings History for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.